European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
CancerWorld Issue #110 (December) is Live
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
1 event,
The ESMO Gastrointestinal Cancers Congress 2026 will be held from 1 to 4 July in Munich, Germany, and online. This major event brings together global experts, researchers, and healthcare professionals focused on improving prevention, diagnosis, and treatment across the full spectrum of gastrointestinal cancers. With a programme featuring expert-led discussions, tumour boards, clinical debates, and […] |
0 events,
|
|||
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by the European Society for Medical Oncology (ESMO), the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez […] |
||
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|